Professional Media briefs: October 2013

Share this article:
Professional Media briefs: October 2013
Professional Media briefs: October 2013

Wolters Kluwer launched the healthcare industry's first electronic nurses references focusing solely on oncology and psychiatric drugs. The company designed the two new apps, which are subsets of the larger Nursing Drug Handbook, for iPhones, iPad and the iPod Touch. The oncology app lists 169 antineoplastic drugs and the psychiatry app has 240 drugs that treat disorders and conditions, making it easier to hone in on the almost 4,000 drugs that are addressed in the Nursing Drug Handbook.

John Wiley & Sons and the American Neurological Association are launching a new online open-access journal, Annals of Clinical and Translational Neurology, with John “Jack” Kessler as Editor-in-Chief. The launch deepens a relationship that dates to 2001 when Wiley started publishing the organization's Annals of Neurology. Articles will be published under a ­Creative Commons license.

The Association of Health Care Journalists named its 2013-2015 board of directors. Some picks: the Philadelphia Inquirer's Karl Stark as president, MedPage Today's Ivan Oransky as VP, the Providence Journal's Felice Freyer as treasurer and Kaiser Health News's Julie Appleby as secretary.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?